ITGR Integer Holdings Corporation

Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025

Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025

~ Attendees Invited to Visit Integer at Booth #1439 ~

PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California.

Integer welcomes visitors to booth #1439 to learn more about the company’s commitment to customers as their partner of choice in enhancing the lives of patients through access to innovative technologies, superior quality and dependable manufacturing to accelerate speed to market and reduce product development risk.

Integer’s exhibit will showcase capabilities and solutions to enable cardio and vascular, cardiac rhythm management and neuromodulation products, and how the company blends technology, expertise and resources to amplify customers’ innovation.  

Integer will additionally highlight its global rapid prototyping services that enable customers’ direct access to a team of dedicated experts in R&D and engineering. With a local-to-local approach and as little as a two-week turnaround, customers now can obtain rapid prototypes in specialized cardiovascular markets, including structural heart, electrophysiology and neurovascular. Offerings include catheter shafts and guidewires, steerable sheaths, introducers, braiding and textiles, and machined components.

“As we expand our capabilities and capacity through ongoing strategic investments, we will continue to anticipate our customers’ needs in a highly innovative and rapidly evolving medical device landscape,” said Payman Khales, President, Cardio and Vascular. “We look forward to demonstrating our collaborative approach, continued commitment to innovation, and the strategic value we provide as our customers’ trusted and reliable end-to-end partner in medical device technologies.”

Integer will also showcase a range of key product areas throughout the event, including:

  • Cardiac rhythm management and neuromodulation: Miniaturized technology for finished IPGs as well as Gen 3 Li Ion and Gen 2 CFx batteries.
  • Cardio and vascular solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.

In addition to Integer’s exhibit at booth #1439, MD&M West 2025 attendees can visit Pulse Technologies, an Integer Company, at booth #2854 to learn more about HSR technology and complex micro machining for critical medical device components.

Attendees are also invited to visit Precision Coating at booth #2269. Integer acquired substantially all of the assets of Precision Coating, a privately held manufacturer specializing in high value surface coating technology platforms, including fluoropolymer, anodic coatings, ion treatment solutions and laser processing, on Jan. 7, 2025, for $152 million, subject to adjustment for additional contingent consideration. Consistent with Integer’s tuck-in acquisition strategy, the acquisition of Precision Coating increases Integer’s service offerings to include differentiated and proprietary coatings capabilities that position Integer to better meet customers’ evolving needs.

Integer will share additional details on this acquisition during its fourth quarter and full year 2024 earnings call on Feb. 20, 2025.

Learn more about Integer at .

About Integer®

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at .

Investor Relations:Media Relations:
Andrew Senn Kelly Butler
763.951.8312469.731.6617


EN
03/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integer Holdings Corporation

Integer Holdings Corp: 1 director

A director at Integer Holdings Corp sold/gave away/sold after exercising options 362,975 shares at 0.000USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...

 PRESS RELEASE

Integer to Present at Bank of America Securities Health Care Conferenc...

Integer to Present at Bank of America Securities Health Care Conference on May 14 PLANO, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2025 Bank of America Securities Health Care Conference, to be held May 13-15, 2025, in Las Vegas. Members of the Integer executive leadership team will participate in a fireside chat on Wednesday, May 14, at 10:00 a.m. PT. A live webcast of the presentation will be accessible under “News & Event...

 PRESS RELEASE

Integer Announces CEO Succession Plan

Integer Announces CEO Succession Plan ~ Joseph Dziedzic to retire as President and CEO ~~ Payman Khales appointed President and CEO effective October 24, 2025 ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the President and CEO position ...

 PRESS RELEASE

Integer Holdings Corporation Reports First Quarter 2025 Results

Integer Holdings Corporation Reports First Quarter 2025 Results ~ Strong start to the year with 1Q25 financial results ~~ Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 28, 2025.   First Quarter 2025 Highlights (compared to First Quarter 2024, except as noted) Sales increased 7% to $437 million, with organic growth of 6%.GAAP operating income increased $11 million to $50 million, an increase of 2...

 PRESS RELEASE

Integer Holdings Corporation Issues Statement on Tariffs

Integer Holdings Corporation Issues Statement on Tariffs ~ Announced tariffs expected to have an immaterial impact on the Company’s 2025 results ~ PLANO, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading contract development and manufacturing organization, issued a statement on the impact of tariffs on its business given the recent extraordinary developments regarding trade policies. “We continue to estimate an impact of $1 to $5 million on full year adjusted operating income, consistent with previous communications. This estimate assumes cu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch